Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcomes of Patients With Familial Transthyretin Amyloidosis After Liver Transplantation.

Progress in transplantation (Aliso Viejo, Calif.) - 1 Sept 2017

Banerjee Dipti, Roeker Lindsey E, Grogan Martha, Swiecicki Paul, Poterucha John, Heimbach Julie, Zeldenrust Steve, Gertz Morie, Edwards Brooks, Daly Richard, Klarich Kyle W, Dispenzieri Angela

Abstract excerpt

BACKGROUND: Familial transthyretin amyloidosis is a disease caused by misfolded transthyretin aggregates that can impair multiple organ systems. Liver transplantation is the first-line treatment for familial transthyretin amyloidosis. RESEARCH QUESTION: Our objective is to study outcomes and survival among patients with familial transthyretin amyloidosis after transplantation. DESIGN: All patients undergoing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid Neuropathies, Familial
Share to Heart Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kidney Transplantation

Share to Liver Transplantation

Share to Mutation

Share to Survival Rate

Share to Treatment Outcome

Source

Identifiers

PMID: 29187090
DOI: 10.1177/1526924817715463

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcomes of Patients With Familial Transthyretin Amyloidosis After Liver Transplantation.PMID 29187090Read ↗

Liver transplantation in transthyretin amyloidosis: issues and challenges.Semantic proximity Read ↗

Outcome in patients treated with isolated liver transplantation for familial transthyretin amyloidosis to prevent cardiomyopathy.Semantic proximity Read ↗

Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry.Semantic proximity Read ↗

Poor outcome after liver transplantation for transthyretin amyloid neuropathy in a family with an Ala36Pro transthyretin mutation: case report.Semantic proximity Read ↗

Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?Semantic proximity Read ↗

Outcome of liver transplantation for familial amyloidotic polyneuropathy.Semantic proximity Read ↗

Acquired transthyretin amyloidosis after domino liver transplant: Phenotypic correlation, implication of liver retransplantation.Semantic proximity Read ↗

Clinicopathological and biochemical findings of thyroid amyloid in hereditary transthyretin amyloidosis with and without liver transplantation.Semantic proximity Read ↗

Liver transplantation for hereditary transthyretin amyloidosis.Semantic proximity Read ↗

End-stage renal failure due to transthyretin amyloidosis after liver transplantation: outcomes in 19 registry cases.Semantic proximity Read ↗

Report from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR) and the Domino Liver Transplant Registry (DLTR).Semantic proximity Read ↗

[Transthyretin-related hereditary amyloidosis].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.